Corrigendum: Stylopine: a potential natural metabolite to block vascular endothelial growth factor receptor 2 (VEGFR2) in osteosarcoma therapy.
Velayutham NK, Thamaraikani T, Wahab S, Khalid M, Ramachawolran G, Abullais SS, Wong LS, Sekar M, Gan SH, Ebenezer AJ, Ravikumar M, Subramaniyan V, Izzati Mat Rani NN, Wu YS, Jeyabalan S.
Velayutham NK, et al. Among authors: thamaraikani t.
Front Pharmacol. 2024 Jan 17;15:1343756. doi: 10.3389/fphar.2024.1343756. eCollection 2024.
Front Pharmacol. 2024.
PMID: 38299157
Free PMC article.